Inhibition of NF-κB Activation and Its Target Genes by Heparin-Binding Epidermal Growth Factor-Like Growth Factor

Journal of Immunology

Volumn 171, Issue 11, 2003, Pages 6014-6022

  Mehta, Veela B ^a   Besner, Gail E ^a,b  

^a OHIO STATE UNIVERSITY   (United States)

^b NATIONWIDE CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; DNA; GAMMA INTERFERON; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 8; NITRIC OXIDE;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL LINE; CELL PROTECTION; CONTROLLED STUDY; CYTOKINE RELEASE; DNA BINDING; GENE TARGETING; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION;

EID: 0344585432     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.171.11.6014     Document Type: Article

References (45)

1. Davis-Fleischer, K. M., and G. E. Besner. 1998. Structure and function of heparin-binding EGF-like growth factor (HB-EGF). Front. Biosci. 3:d288.
2. Iwamoto, R., and E. Mekada. 2000. Heparin-binding EGF-like growth factor: a juxtacrine growth factor. Cytokine Growth Factor Rev. 11:335.
3. Besner, G., S. Higashiyama, and M. Klagsbrun. 1990. Isolation and characterization of a macrophage-derived heparin-binding growth factor. Cell Regul. 1:811.
4. Homma, T., M. Sakai, H. F. Cheng, T. Yasuda, R. J. Coffey, Jr., and R. C. Harris. 1995. Induction of heparin-binding epidermal growth factor-like growth factor mRNA in rat kidney after acute injury. J. Clin. Invest. 96:1018.
5. Casola, A., R. P. Garofalo, S. E. Crawford, M. K. Estes, F. Mercurio, S. E. Crowe, and A. R. Brasier. 2002. Interleukin-8 gene regulation in intestinal epithelial cells infected with rotavirus: role of viral-induced IκB kinase activation. Virology 298:8.
6. Laroux, F. S., K. P. Pavlick, R. E. Wolf, and M. B. Grisham. 2001. Dysregulation of intestinal mucosal immunity: implications in inflammatory bowel disease. News Physiol. Sci. 16:272.
7. McCafferty, D. M. 2000. Peroxynitrite and inflammatory bowel disease. Gut 46:436.
8. Pavlick, K. P., F. S. Laroux, J. Fuseler, R. E. Wolf, L. Gray, J. Hoffman, and M. B. Grisham. 2002. Role of reactive metabolites of oxygen and nitrogen in inflammatory bowel disease. Free Radical Biol. Med. 33:311.
9. Xie, Q. W., Y. Kashiwabara, and C. Nathan. 1994. Role of transcription factor NF-κB/Rel in induction of nitric oxide synthase. J. Biol. Chem. 269:4705.
10. Salzman, A. L., T. Eaves-Pyles, S. C. Linn, A. G. Denenberg, and C. Szabo. 1998. Bacterial induction of inducible nitric oxide synthase in cultured human intestinal epithelial cells. Gastroenterology 114:93.
11. Molina-Holgado, E., A. Arevalo-Martin, A. Castrillo, L. Bosca, J. M. Vela, and C. Guaza. 2002. Interleukin-4 and interleukin-10 modulate nuclear factor κB activity and nitric oxide synthase-2 expression in Theiler's virus-infected brain astrocytes. J. Neurochem. 81:1242.
12. Conner, E. M., S. Brand, J. M. Davis, F. S. Laroux, V. J. Palombella, J. W. Fuseler, D. Y. Kang, R. E. Wolf, and M. B. Grisham. 1997. Proteasome inhibition attenuates nitric oxide synthase expression, VCAM-1 transcription and the development of chronic colitis. J. Pharmacol. Exp. Ther. 282:1615.
13. Elewaut, D., J. A. DiDonato, J. Mogg Kim, F. Truong, L. Eckmann, and M. F. Kagnoff. 1999. NF-κB is a central regulator of the intestinal epithelial cell innate immune response induced by infection with enteroinvasive bacteria. J. Immunol. 163:1457.
14. Verma, I. M., J. K. Stevenson, E. M. Schwarz, D. Van Antwerp, and S. Miyamoto. 1995. Rel/NF-κB/IκB family: intimate tales of association and dissociation. Genes Dev. 9:2723.
15. DiDonato, J. A., M. Hayakawa, D. M. Rothwarf, E. Zandi, and M. Karin. 1997. A cytokine-responsive IκB kinase that activates the transcription factor NF-κB. Nature 388:548.
16. Karin, M. 1999. How NF-κB is activated: the role of the IκB kinase (IKK) complex. Oncogene 18:6867.
17. DiDonato, J. A., F. Mercurio, and M. Karin. 1995. Phosphorylation of IκBα precedes but is not sufficient for its dissociation from NF-κB. Mol. Cell. Biol. 15:1302.
18. Farakas, L. M., and K. K. 2002. Heparin-binding epidermal growth factor-like growth factor (HB-EGF) regulates survival of midbrain dopaminergic neurons. J. Neural. Transm. 109:267.
19. Takemura, T., S. Kondo, T. Homma, M. Sakai, and R. C. Harris. 1997. The membrane-bound form of heparin-binding epidermal growth factor-like growth factor promotes survival of cultured renal epithelial cells. J. Biol. Chem. 272:31036.
20. Miyoshi, E., S. Higashiyama, T. Nakagawa, N. Hayashi, and N. Taniguchi. 1997. Membrane-anchored heparin-binding epidermal growth factor-like growth factor acts as a tumor survival factor in a hepatoma cell line. J. Biol. Chem. 272:14349.
21. Lara-Marquez, M. L., V. Mehta, M. P. Michalsky, J. B. Fleming, and G. E. Besner. 2002. Heparin-binding EGF-like growth factor down regulates proinflammatory cytokine-induced nitric oxide and inducible nitric oxide synthase production in intestinal epithelial cells. Nitric Oxide 6:142.
22. Xia, G., M. Lara-Marquez, M. H. Luquette, S. Glenn, A. Haque, and G. E. Besner. 2001. Heparin-binding EGF-like growth factor decreases inducible nitric oxide synthase and nitric oxide production after intestinal ischemia/ reperfusion injury. Antioxid. Redox Signal. 3:919.
23. Pillai, S. B., C. E. Hinman, M. H. Luquette, P. T. Nowicki, and G. E. Besner. 1999. Heparin-binding epidermal growth factor-like growth factor protects rat intestine from ischemia/reperfusion injury. J. Surg. Res. 87:225.
24. Kuhn, M. A., G. Xia, V. B. Mehta, S. Glenn, M. P. Michalsky, and G. E. Besner. 2002. Heparin-binding EGF-like growth factor (HB-EGF) decreases oxygen free radical production in vitro and in vivo. Antioxid. Redox. Signal. 4:639.
25. Michalsky, M. P., A. Kuhn, V. Mehta, and G. E. Besner. 2001. Heparin-binding EGF-like growth factor decreases apoptosis in intestinal epithelial cells in vitro. J. Pediatr. Surg. 36:1130.
26. Davis, K. M., D. R. Brigstock, P. R. Johnson, M. A. Crissman-Combs, D. W. McCarthy, M. T. Downing, and G. E. Besner. 1996. Production of glycosylated heparin-binding EGF-like growth factor in HeLa cells using vaccinia virus. Protein Express. Purif. 8:57.
27. Dignam, J. D., R. M. Lebovitz, and R. G. Roeder. 1983. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11:1475.
28. DiDonato, J. A. 2000. Assaying for IκB kinase activity. Methods Enzymol. 322:393.
29. Flodstrom, M., N. Welsh, and D. L. Eizirik. 1996. Cytokines activate the nuclear factor κB (NF-κB) and induce nitric oxide production in human pancreatic islets. FEBS Lett. 385:4.
30. Foehr, E. D., X. Lin, A. O'Mahony, R. Geleziunas, R. A. Bradshaw, and W. C. Greene. 2000. NF-κB signaling promotes both cell survival and neurite process formation in nerve growth factor-stimulated PC12 cells. J. Neurosci. 20:7556.
31. Fang, L., G. Li, G. Liu, S. W. Lee, and S. A. Aaronson. 2001. p53 induction of heparin-binding EGF-like growth factor counteracts p53 growth suppression through activation of MAPK and PI3K/Akt signaling cascades. EMBO J. 20:1931.
32. Iwamoto, R., S. Yamazaki, M. Asakura, S. Takashima, H. Hasuwa, K. Miyado, S. Adachi, M. Kitakaze, K. Hashimoto, G. Raab, et al. 2003. Heparin-binding EGF-like growth factor and ErbB signaling is essential for heart function. Proc. Natl. Acad. Sci. USA 100:3221.
33. Jung, H. C., L. Eckmann, S. K. Yang, A. Panja, J. Fierer, E. Morzycka-Wroblewska, and M. F. Kagnoff. 1995. A distinct array of proinflammatory cytokines is expressed in human colon epithelial cells in response to bacterial invasion. J. Clin. Invest. 95:55.
34. Digicaylioglu, M., and S. A. Lipton. 2001. Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-κB signalling cascades. Nature 412:641.
35. Zingarelli, B., S. Cuzzocrea, C. Szabo, and A. L. Salzman. 1998. Mercaptoethylguanidine, a combined inhibitor of nitric oxide synthase and peroxynitrite scavenger, reduces trinitrobenzene sulfonic acid-induced colonic damage in rats. J. Pharmacol. Exp. Ther. 287:1048.
36. Didonato, J. A., F. Saatcioglu, and M. Karin. 1996. Molecular mechanisms of immunosuppression and anti-inflammatory activities by glucocorticoids. Am. J. Respir. Crit. Care Med. 154:S11.
37. Matsumura, M., H. Kakishita, M. Suzuki, N. Banba, and Y. Hattori. 2001. Dexamethasone suppresses iNOS gene expression by inhibiting NF-κB in vascular smooth muscle cells. Life Sci. 69:1067.
38. Milligan, S. A., M. W. Owens, and M. B. Grisham. 1996. Inhibition of IκB-α and IκB-β proteolysis by calpain inhibitor I blocks nitric oxide synthesis. Arch. Biochem. Biophys. 335:388.
39. Schottelius, A. J., M. W. Mayo, R. B. Sartor, and A. S. Baldwin, Jr. 1999. Interleukin-10 signaling blocks inhibitor of κB kinase activity and nuclear factor κB DNA binding. J. Biol. Chem. 274:31868.
40. Thogersen, V. B., B. S. Sorensen, S. S. Poulsen, T. F. Orntoft, H. Wolf, and E. Nexo. 2001. A subclass of HER1 ligands are prognostic markers for survival in bladder cancer patients. Cancer Res. 61:6227.
41. Leu, C. M., C. Chang, and C. Hu. 2000. Epidermal growth factor (EGF) suppresses staurosporine-induced apoptosis by inducing mcl-1 via the mitogen-activated protein kinase pathway. Oncogene 19:1665.
42. Senftleben, U., and M. Karin. 2002. The IKK/NF-κB pathway. Crit. Care Med. 30:S18.
43. Verma, Q. L. I. M. 2002. NF-κB regulation in the immune system. Nat. Rev. Immunol. 2:725.
44. Lechman, E. R., D. Jaffurs, S. C. Ghivizzani, A. Gambotto, I. Kovesdi, Z. Mi, C. H. Evans, and P. D. Robbins. 1999. Direct adenoviral gene transfer of viral IL-10 to rabbit knees with experimental arthritis ameliorates disease in both injected and contralateral control knees. J. Immunol. 163:2202.
45. Morishita. R., T. Sugimoto, M. Aoki, I. Kida, N. Tomita, A. Moriguchi, K. Maeda, Y. Sawa, Y. Kaneda, J. Higaki, et al. 1997. In vivo transfection of cis element "decoy" against nuclear factor-κB binding site prevents myocardial infarction. Nat. Med. 3:894.